CrushSCI.com
90.2平均天数
100中位天数
39最短天数
128最长天数
2562025发文量

Paper Review Records

全部论文审稿周期

5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

39 天

Hearing Intervention for Older Adults With Mild Cognitive Impairment

作者
Ying Chen; Haibo Shi; Mingliang Xiang; Xia Li; Zhili Wang; Wen Lu; Yilin Shen; Yuan Fang; Jie Chen; Lei Guan; Feifan Zhao; Zaichao Wu; Rong Tian; Qiongfei Yu; Kun Han; Haibin Sheng; Shengqi Chen; Jiayu Sun; Guangyu Liu; Hao Wu展开收起
作者单位
1. Department of Otolaryngology-Head and Neck Surgery, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 2. Ear Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 3. Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases (14DZ2260300), Shanghai, China; 4. Department of Audiology & Speech-Language Pathology, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 5. Department of Otolaryngology-Head and Neck Surgery, Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 6. Department of Otolaryngology-Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 7. Department of Psychogeriatrics, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China展开收起
官方全文证据 DOI 网页
100 天

Common MC1R Variants and Parkinson Disease Progression

作者
Jackson G. Schumacher; Xinyuan Zhang; Jian Wang; Johannes M. Dijkstra; Hirohisa Watanabe; Xiang Gao; Marianna Cortese; Eric A. Macklin; Michael A. Schwarzschild; Xiqun Chen展开收起
作者单位
1. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; 2. Aligning Science Across Parkinson’s Collaborative Research Network, Chevy Chase, Maryland; 3. Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; 4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston; 5. Department of Neurology, School of Medicine, Fujita Health University, Toyoake, Japan; 6. Department of Nutritional Sciences, The Pennsylvania State University, University Park; 7. Now with Department of Nutrition and Food Hygiene, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, China; 8. Departments of Epidemiology and Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts展开收起
官方全文证据 DOI 网页
118 天

Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease

作者
Clara Bueno Lopez; Andri Iona; Iain Turnbull; Huaidong Du; Yiping Chen; Ling Yang; Alexander Tinworth; Zhengjie Shen; Kshitij Kolhe; Pei Pei; Canqing Yu; Dianjianyi Sun; Jun Lv; Junshi Chen; Robert Clarke; Rory Collins; Richard Peto; Liming Li; Fiona Bragg; Zhengming Chen展开收起
作者单位
1. Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; 2. Noncommunicable Diseases Prevention and Control Department, Tongxiang Center for Disease Control and Prevention, Tongxiang, China; 3. Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China; 4. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China; 5. Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China; 6. China National Center for Food Safety Risk Assessment, Chaoyang District, Beijing, China; 7. Health Data Research UK Oxford, University of Oxford, Oxford, United Kingdom展开收起
官方全文证据 DOI 网页
66 天

Tirofiban for Branch Atheromatous Disease–Related Stroke

作者
Yicong Wang; Xiaoling Liao; Shuo Feng; Yuesong Pan; Xuan Wang; Hui Qu; Yuetong Liu; Cong Gao; Xinru Liu; Qianqian Yang; Meiyang Zhang; Zhangxinyi Liu; Jinyi Ye; Yuke Mao; Weiqi Chen; Lingling Jiang; Philip M. Bath; S. Claiborne Johnston; Guillaume Turc; Xingquan Zhao; Yongjun Wang; Yilong Wang展开收起
作者单位
1. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; 2. National Clinical Research Center for Neurological Diseases, Beijing, China; 3. Department of Neurology, Qilu Hospital of Shandong University, Jinan, China; 4. Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, Nottingham, United Kingdom; 5. University of California, San Francisco; 6. INSERM U1266, Institute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, Paris, France; 7. GHU Paris Psychiatrie et Neurosciences, Paris, France; 8. National Center for Neurological Disorders, Beijing, China; 9. Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China; 10. Advanced Innovation Center for Human Brain Protection, Beijing, China; 11. Beijing Laboratory of Oral Health, Beijing, China; 12. Chinese Institute for Brain Research, Beijing, China; 13. Laboratory for Clinical Medicine, Capital Medical University, Beijing, China展开收起
官方全文证据 DOI 网页
128 天

Management of Exacerbations and Rescue Therapy in the Phase 3 Myasthenia Gravis Inebilizumab Trial

作者
Richard J. Nowak; Kimiaki Utsugisawa; Michael Benatar; Emma Ciafaloni; M. Isabel Leite; John Vissing; Fengming Tang; Yanping Wu; Catherine Najem; Sue Cheng; James F. Howard展开收起
作者单位
1. Program for Clinical and Translational Neuromuscular Research, Department of Neurology, Yale School of Medicine, Yale University, New Haven, Connecticut; 2. Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan; 3. Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida; 4. Department of Neurology, University of Rochester, Rochester, New York; 5. Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom; 6. Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 7. Rare Diseases Unit, Amgen, Thousand Oaks, California; 8. Department of Neurology, University of North Carolina, Chapel Hill展开收起
官方全文证据 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。